findmyKOL
Clinical trialNCT00952588CompletedPhase 2/PHASE3Interventional

Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients

SponsorAstraZenecaEnrollment74Acute Myeloid Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Research Site

    Westmead, New South Wales, Australia

  • Research Site

    Herston, Queensland, Australia

  • Research Site

    Melbourne, Victoria, Australia

  • Research Site

    Parkville, Victoria, Australia

France
  • Research Site

    Angers, France

  • Research Site

    Clermont-Ferrand, France

  • Research Site

    Grenoble, France

  • Research Site

    Lyon, France

  • Research Site

    Marseille, France

  • Research Site

    Nantes, France

Germany
  • Research Site

    Duisburg, Germany

  • Research Site

    Erlangen, Germany

  • Research Site

    Frankfurt, Germany

  • Research Site

    Münster, Germany

  • Research Site

    Villingen-Schwenningen, Germany

Italy
  • Research Site

    Bologna, BO, Italy

  • Research Site

    Genova, GE, Italy

  • Research Site

    Orbassano, TO, Italy

  • Research Site

    Udine, UD, Italy

  • Research Site

    Roma, Italy

Japan
  • Research Site

    Nagoya, Aichi-ken, Japan

  • Research Site

    Yoshida-gun, Fukui, Japan

  • Research Site

    Maebashi, Gunma, Japan

  • Research Site

    Isehara, Kanagawa, Japan

  • Research Site

    Yokohama, Kanagawa, Japan

  • Research Site

    Chūō, Tokyo, Japan

  • Research Site

    Fukuoka, Japan

Romania
  • Research Site

    Brasov, Romania

  • Research Site

    TG Mures, Romania

Spain
  • Research Site

    Badalona(barcelona), Catalonia, Spain

  • Research Site

    Barcelona, Catalonia, Spain

  • Research Site

    Madrid, Madrid, Spain

  • Research Site

    Majadahonda, Madrid, Spain

  • Research Site

    Oviedo, Principality of Asturias, Spain

  • Research Site

    Valencia, Valencia, Spain

United Kingdom
  • Research Site

    Brighton, United Kingdom

  • Research Site

    London, United Kingdom

United States
  • Research Site

    Atlanta, Georgia, United States

  • Research Site

    Chicago, Illinois, United States

  • Research Site

    New York, New York, United States

5 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BarasertibLDAC
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2009
Primary completion
30 Jun 2011
Completion
30 Jun 2011
Last update posted
24 Feb 2020
Registered enrollment
74
Registry id
NCT00952588
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.